Skip to content

Investigation of the target and efficacy of transcranial alternating current stimulation for chronic insomnia

Investigation of the target and efficacy of transcranial alternating current stimulation for chronic insomnia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063729
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic sleep disorders

Interventions

Group 1 :placebo control
Group 2:tACS

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Chronic insomnia case group: outpatients/inpatients diagnosed with ICSD-3 chronic insomnia, aged 18-75 years, right-handed; 2. The diagnosis meets the diagnostic criteria of ICSD-3 Chronic Insomnia Disorder; 3. ISI >= 8 points; 4. Have not used physical therapy in the past 6 months, such as: MECT, rTMS, tES, acupuncture, etc.; 5. Have not used sedative hypnotics, antidepressants, antipsychotics, mood stabilizers or other drugs that can act on the central nervous system within at least 4 weeks of this episode; 6. Non-shift workers; 7. The total course of disease = 5 years.

Exclusion criteria

Exclusion criteria: 1. Persons with any mental disorder (MINI) at present or in the past; 2. Years of education < 5 years or IQ < 90 points; 3. Travelers across time zones within 3 months; 4. Have the habit of eating probiotics and prebiotic products; 5. Nervous system diseases, trauma-induced loss of consciousness, chronic physical diseases, brain organic diseases, and tumor patients; 6. There are currently other sleep disorders other than insomnia: PLMS, RLS, etc.; 7. Those who drank alcohol within 1 week before enrollment; 8. Drink coffee in the afternoon before the experiment; 9. Patients with clear contraindications of MRI and tACS.

Design outcomes

Primary

MeasureTime frame
polysomnography;Insomnia Severity Index;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Montreal Cognitive Assessment;Number Sign Conversion Quiz;

Countries

China

Contacts

Public ContactYanyan Wang

West China Hospital of Sichuan University

Kittyanwang520@scu.edu.cn+86 18140052755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026